Cargando…
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways
BACKGROUND: Despite recent advances in diagnosis and treatment, prostate cancer (PCa) remains the leading cause of cancer-related deaths in men. Current treatments offered in the clinics are often toxic and have severe side effects. Hence, to treat and manage PCa, new agents with fewer side effects...
Autores principales: | Ward, Ashley B., Mir, Hina, Kapur, Neeraj, Gales, Dominique N., Carriere, Patrick P., Singh, Shailesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001031/ https://www.ncbi.nlm.nih.gov/pubmed/29898731 http://dx.doi.org/10.1186/s12957-018-1400-z |
Ejemplares similares
-
Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer
por: Carriere, Patrick P., et al.
Publicado: (2018) -
Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways
por: Saunders, Ian T., et al.
Publicado: (2019) -
Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer
por: King Thomas, Jeronay, et al.
Publicado: (2019) -
CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival
por: Thomas, Jeronay K., et al.
Publicado: (2019) -
CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling
por: Mir, Hina, et al.
Publicado: (2021)